ORNELLO, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 7.329
EU - Europa 4.128
AS - Asia 4.125
SA - Sud America 1.038
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
AN - Antartide 1
Totale 16.742
Nazione #
US - Stati Uniti d'America 7.141
SG - Singapore 1.910
RU - Federazione Russa 1.140
BR - Brasile 877
IE - Irlanda 747
IT - Italia 663
CN - Cina 624
VN - Vietnam 558
HK - Hong Kong 451
DE - Germania 382
FI - Finlandia 197
GB - Regno Unito 166
NL - Olanda 162
SE - Svezia 160
FR - Francia 159
TR - Turchia 127
IN - India 90
CA - Canada 84
UA - Ucraina 80
MX - Messico 69
BD - Bangladesh 67
AR - Argentina 63
PL - Polonia 54
JP - Giappone 48
ZA - Sudafrica 48
CZ - Repubblica Ceca 39
ES - Italia 39
AT - Austria 38
IQ - Iraq 31
ID - Indonesia 30
EC - Ecuador 29
BE - Belgio 27
PK - Pakistan 23
LT - Lituania 21
UZ - Uzbekistan 18
CO - Colombia 17
CL - Cile 16
MY - Malesia 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 12
KZ - Kazakistan 12
MA - Marocco 12
SA - Arabia Saudita 12
ET - Etiopia 11
IR - Iran 11
PH - Filippine 11
NP - Nepal 8
PE - Perù 8
PY - Paraguay 8
AZ - Azerbaigian 7
KR - Corea 7
TN - Tunisia 7
CH - Svizzera 6
DZ - Algeria 6
EG - Egitto 6
HN - Honduras 6
HR - Croazia 6
IL - Israele 6
KE - Kenya 6
RS - Serbia 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EU - Europa 5
HU - Ungheria 5
JM - Giamaica 5
LV - Lettonia 5
TH - Thailandia 5
AU - Australia 4
CY - Cipro 4
DK - Danimarca 4
GR - Grecia 4
JO - Giordania 4
PA - Panama 4
PS - Palestinian Territory 4
BB - Barbados 3
CR - Costa Rica 3
KH - Cambogia 3
MM - Myanmar 3
NO - Norvegia 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MN - Mongolia 2
OM - Oman 2
RO - Romania 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BM - Bermuda 1
Totale 16.717
Città #
Dallas 1.258
Singapore 1.090
San Jose 944
Dublin 735
Chandler 709
Ashburn 601
Hong Kong 434
Santa Clara 357
Jacksonville 295
Boardman 289
The Dalles 264
New York 204
Ho Chi Minh City 182
Moscow 175
Los Angeles 143
Council Bluffs 133
Hanoi 131
Beijing 108
Munich 104
Amsterdam 98
Lauterbourg 92
São Paulo 84
Lappeenranta 81
Wilmington 78
Hefei 77
Lawrence 71
Princeton 71
Izmir 60
Milan 59
Helsinki 53
Verona 51
Warsaw 51
Rome 49
Nanjing 47
Turku 47
Falkenstein 45
Kitzingen 43
Tokyo 42
Orem 41
Da Nang 38
Frankfurt am Main 35
London 35
Columbus 34
L’Aquila 34
Seattle 34
Benevento 32
Denver 32
Rio de Janeiro 32
Bremen 31
Brooklyn 30
Chennai 30
Montreal 30
Des Moines 29
Atlanta 28
Poplar 28
San Mateo 28
Stockholm 28
Brussels 27
Johannesburg 27
Mexico City 27
San Francisco 27
Brno 25
Haiphong 24
Toronto 24
Ann Arbor 22
Chicago 21
Woodbridge 21
Curitiba 20
Shanghai 20
Boston 19
Spoltore 18
Belo Horizonte 17
Brasília 17
Dearborn 17
Houston 17
L'aquila 17
Manchester 17
Nuremberg 17
Vienna 16
Phoenix 15
Tashkent 15
Düsseldorf 14
Olomouc 14
Bologna 13
Dhaka 13
Ankara 12
Palermo 12
Campinas 11
Changsha 11
Charlotte 11
Guangzhou 11
Jakarta 11
Mumbai 11
Salvador 11
Baghdad 10
Florence 10
Fortaleza 10
Goiânia 10
Nanchang 10
Naples 10
Totale 10.666
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 347
The Epidemiology of Atrial Fibrillation and Stroke 195
Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation 180
Composite Scores and Other Outcome Measures in Stroke Trials 165
Declining incidence of intracerebral hemorrhage over two decades in a population-based study 165
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage 162
Age‐Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 162
Epidemiology of Transient Ischemic Attacks Using Time- or Tissue-Based Definitions: A Population-Based Study 157
Translation and Transcultural Adaptation of the Wessex Head Injury Matrix, Italian Version: A Preliminary Report 154
O032. Associations between any headache and obesity: results from a systematic review and meta-analysis of observational studies 151
C-Reactive Protein elevation and subsequent atrial fibrillation detection after ischemic stroke treated with mechanical thrombectomy: an inverse probability weighting analysis 150
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 149
Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities 144
Migraine and hemorrhagic stroke: data from general practice 144
Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies 144
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 141
The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis 138
Migraine and body mass index categories: a meta-analysis of observational studies 138
The challenge of driving BCI with emotional signals collected by EEG 137
Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes A Systematic Review and Meta-Analysis 137
The role of inflammation in neurological disorders 137
Magnetic Resonance-guided Focused Ultrasound thalamotomy for refractory neuropathic pain: a systematic review and critical appraisal of current knowledge 137
Carotid artery stenting during endovascular thrombectomy for acute ischemic stroke with tandem occlusion: the Italian Registry of Endovascular Treatment in Acute Stroke 136
The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal 131
Clinical usefulness of Edinburgh CT criteria in patients with lobar intracerebral hemorrhage 129
White matter hyperintensities in migraine are not mediated by a dysfunction of the glymphatic system-A diffusion tensor imaging magnetic resonance imaging study 127
Resistant and refractory migraine – two different entities with different comorbidities? Results from the REFINE study 126
Medication overuse and drug addiction: a narrative review from addiction perspective 122
Migraine in menopausal women: a systematic review 121
Insulin resistance in migraineurs: Results from a case-control study 121
Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials 120
Migraine and hemorrhagic stroke: a meta-analysis 119
Symptoms of gait and coordination impairment in a patient with COVID-19 interstitial pneumonia 119
Cognitive outcomes after focused ultrasound thalamotomy for tremor: Results from the COGNIFUS (COGNitive in Focused UltraSound) study 118
Evidence-based guidelines for the pharmacological treatment of migraine 117
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine 117
Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial 117
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 115
O059. Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center 115
Characteristics and outcomes of intracerebral hemorrhage in a population-based stroke registry 115
Peripheral vascular dysfunction in migraine: a review 112
Association between response to triptans and response to erenumab: real-life data 112
How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice 108
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting 107
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 107
O050. Chronic daily headache and body mass index: a meta-analysis of observational studies 106
Erenumab Plus Subcutaneous Immunoglobulin in a Patient With Comorbid Chronic Migraine and Myasthenia Gravis 105
Applying a biopsychosocial model to migraine: rationale and clinical implications 104
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe) 104
The COVID-19 Pandemic as an Opportunity to Improve Health Care Through a Nurse-Coordinated Multidisciplinary Model in a Headache Specialist Center: The Implementation of a Telemedicine Protocol 104
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 103
Migraine during covid-19: Data from second wave pandemic in an Italian cohort 103
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 103
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 102
Education and Monitoring of People with Migraine Through a Mobile App: A Prototype Developed by a Multidisciplinary Group 100
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 99
Body composition status and the risk of migraine: A meta-analysis 99
Wear-Off of OnabotulinumtoxinA Effect Over the Treatment Interval in Chronic Migraine: A Retrospective Chart Review With Analysis of Headache Diaries 99
Paralytic ileus after planned abdominal surgery in a patient on treatment with erenumab 99
Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study 98
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 98
Sustained response to onabotulinumtoxin A in patients with chronic migraine: Real-life data 98
ESNR 2020 98
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis 98
Primary stroke centers: are they worthy of an upgrade? 97
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives 97
Do antithrombotic drugs have a role in migraine prevention? A systematic review 96
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 96
Spreading depolarization may link migraine, stroke, and other cardiovascular disease 96
Cerebrovascular reactivity in subjects with migraine: Age paradox? 96
Acute and Preventive Management of Migraine during Menstruation and Menopause 96
Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes 95
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study) 94
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial 94
Cerebral vascular reactivity and the migraine-stroke relationship: A narrative review 94
Outcomes of Mechanical Thrombectomy in Patients With Ischemic Stroke and Heart Failure. A Systematic Review and Meta‐analysis 93
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 93
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 92
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 92
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 91
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 90
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 90
Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis 90
Headache diagnosis in children and adolescents: validation of the Italian version of the HARDSHIP questionnaire 90
Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region 90
Efficacy and safety of greater occipital nerve block for the treatment of cluster headache: a systematic review and meta-analysis 88
INTERDISCIPLINARY INTER-OBSERVER AGREEMENT AND ACCURACY OF THE NEW SIMPLIFIED EDINBURGH CT CRITERIA FOR CEREBRAL AMYLOID ANGIOPATHY- ASSOCIATED INTRACEREBRAL HAEMORRHAGE 88
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 88
Author response: Body composition status and the risk of migraine: A meta-analysis 86
Social distancing in chronic migraine during the covid-19 outbreak: Results from a multicenter observational study 86
Different effects of air microembolism through patent foramen ovale in patients with migraine: A quantitative electroencephalogram case series 84
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study 84
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy 83
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 83
Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication—a real-world study 82
Correction to: Medication overuse and drug addiction: a narrative review from addiction perspective 82
The paradigm shift of long-term treatments in migraine prevention 82
Efficacy and safety of greater occipital nerve block for the treatment of cervicogenic headache: a systematic review 81
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 81
Acute motor axonal neuropathy and transverse myelitis overlap: the importance of history taking 80
Totale 11.405
Categoria #
all - tutte 69.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 19 80 24
2021/2022498 20 11 45 24 37 7 9 23 33 44 53 192
2022/20231.990 114 139 52 221 129 212 14 118 882 13 51 45
2023/2024816 80 39 48 63 43 208 14 33 10 72 33 173
2024/20253.978 173 53 280 207 383 326 519 281 850 230 347 329
2025/20268.654 398 1.197 844 1.185 871 542 1.194 414 919 1.090 0 0
Totale 17.014